Literature DB >> 17482572

The novel C-terminal KCNQ1 mutation M520R alters protein trafficking.

Nicole Schmitt1, Kirstine Calloe, Nathalie Hélix Nielsen, Maria Buschmann, Erwin-Josef Speckmann, Eric Schulze-Bahr, Martin Schwarz.   

Abstract

The long QT-syndrome is characterized by a prolongation of the QT-interval and tachyarrhythmias causing syncopes and sudden death. We identified the missense mutation M520R in the calmodulin binding domain of the Kv7.1 channel from a German family with long QT-syndrome. Heterologous expression of the mutant did not reveal any whole-cell currents independent of the auxiliary subunit KCNE1. Co-expression of the wild-type Kv7.1 channels and the mutant showed that the mutant did not have a dominant negative effect. In immunocytochemical assays of transfected COS-1 cells wild-type Kv7.1 showed an immunopositive labeling of the plasma membrane. For M520R no plasma membrane staining was visible, instead a strong signal in the ER was observed. These results indicate that the LQT1 mutation M520R leads to ER-retention and dysfunctional trafficking of the mutant channel resulting in haploinsufficiency.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17482572     DOI: 10.1016/j.bbrc.2007.04.127

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

Review 1.  Emerging concepts in the pharmacogenomics of arrhythmias: ion channel trafficking.

Authors:  William T Harkcom; Geoffrey W Abbott
Journal:  Expert Rev Cardiovasc Ther       Date:  2010-08

2.  Enhanced effects of isoflurane on the long QT syndrome 1-associated A341V mutant.

Authors:  Ikuomi Mikuni; Carlos G Torres; Tania Bakshi; Akihito Tampo; Brian E Carlson; Martin W Bienengraeber; Wai-Meng Kwok
Journal:  Anesthesiology       Date:  2015-04       Impact factor: 7.892

Review 3.  Cardiac Delayed Rectifier Potassium Channels in Health and Disease.

Authors:  Lei Chen; Kevin J Sampson; Robert S Kass
Journal:  Card Electrophysiol Clin       Date:  2016-04-01

4.  Enhancing the Predictive Power of Mutations in the C-Terminus of the KCNQ1-Encoded Kv7.1 Voltage-Gated Potassium Channel.

Authors:  Jamie D Kapplinger; Andrew S Tseng; Benjamin A Salisbury; David J Tester; Thomas E Callis; Marielle Alders; Arthur A M Wilde; Michael J Ackerman
Journal:  J Cardiovasc Transl Res       Date:  2015-04-09       Impact factor: 4.132

5.  Recapitulating long-QT syndrome using induced pluripotent stem cell technology.

Authors:  Ralf J Dirschinger; Alexander Goedel; Alessandra Moretti; Karl-Ludwig Laugwitz; Daniel Sinnecker
Journal:  Pediatr Cardiol       Date:  2012-03-13       Impact factor: 1.655

Review 6.  KV7 channelopathies.

Authors:  Snezana Maljevic; Thomas V Wuttke; Guiscard Seebohm; Holger Lerche
Journal:  Pflugers Arch       Date:  2010-04-18       Impact factor: 3.657

7.  A phosphoinositide 3-kinase (PI3K)-serum- and glucocorticoid-inducible kinase 1 (SGK1) pathway promotes Kv7.1 channel surface expression by inhibiting Nedd4-2 protein.

Authors:  Martin Nybo Andersen; Katarzyna Krzystanek; Frederic Petersen; Sofia Hammami Bomholtz; Søren-Peter Olesen; Hugues Abriel; Thomas Jespersen; Hanne Borger Rasmussen
Journal:  J Biol Chem       Date:  2013-11-08       Impact factor: 5.157

8.  Novel mechanisms of trafficking defect caused by KCNQ1 mutations found in long QT syndrome.

Authors:  Akinori Sato; Takuro Arimura; Naomasa Makita; Taisuke Ishikawa; Yoshiyasu Aizawa; Hiroya Ushinohama; Yoshifusa Aizawa; Akinori Kimura
Journal:  J Biol Chem       Date:  2009-10-13       Impact factor: 5.157

9.  Structure of a Ca(2+)/CaM:Kv7.4 (KCNQ4) B-helix complex provides insight into M current modulation.

Authors:  Qiang Xu; Aram Chang; Alexandra Tolia; Daniel L Minor
Journal:  J Mol Biol       Date:  2012-11-23       Impact factor: 5.469

10.  Voltage-gated Nav channel targeting in the heart requires an ankyrin-G dependent cellular pathway.

Authors:  John S Lowe; Oleg Palygin; Naina Bhasin; Thomas J Hund; Penelope A Boyden; Erwin Shibata; Mark E Anderson; Peter J Mohler
Journal:  J Cell Biol       Date:  2008-01-07       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.